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function, which is inherent to its pathophysiology.2-5
Valve repair rather than replacement has been purported
to be associated with superior surgical outcomes in this
patient population.6 Although several techniques of
Ischemic mitral regurgitation (MR) is a common clinicalproblem with a wide spectrum of presentations.1 It is
associated with a high operative mortality and poor long-
term outcome due to left ventricular (LV) systolic dys-
Objective: Incomplete mitral leaflet coaptation during acute left ventricular
ischemia is associated with end-diastolic mitral annular dilatation and
ischemic mitral regurgitation. Annular rings were implanted in sheep to
investigate whether annular reduction alone is sufficient to prevent mitral
regurgitation during acute posterolateral left ventricular ischemia.
Methods: Radiopaque markers were inserted around the mitral anulus, on
papillary muscle tips, and on the central meridian of both mitral leaflets in
three groups of sheep: control (n = 5), Physio ring (n = 5) (Baxter
Cardiovascular Div, Santa Ana, Calif), and Duran ring (n = 6) (Medtronic
Heart Valve Div, Minneapolis, Minn). After 8 ± 1 days, animals were stud-
ied with biplane videofluoroscopy before and during left ventricular
ischemia. Annular area was calculated from 3-dimensional marker coordi-
nates and coaptation defined as minimal distance between leaflet edge
markers.
Results: Before ischemia, leaflet coaptation occurred just after end-diastole
in all groups (control 17 ± 41, Duran 33 ± 30, Physio 33 ± 24 ms, mean ±
SD, P > .2 by analysis of variance). During ischemia, regurgitation was
detected in all control animals, and leaflet coaptation was delayed to 88 ± 8
ms after end-diastole (P = .02 vs preischemia). This was associated with
increased end-diastolic annular area (8.0 ± 0.9 vs 6.7 ± 0.6 cm2, P = .004)
and septal-lateral annular diameter (2.9 ± 0.1 vs 2.5 ± 0.1 cm, P = .02).
Mitral regurgitation did not develop in Duran or Physio sheep, time to coap-
tation was unchanged (Duran 25 ± 25 ms, Physio 30 ± 48 ms [both P > .2 vs
preischemia]), and annular area remained fixed.
Conclusion: Mitral annular area reduction and fixation with an annuloplasty
ring eliminated delayed leaflet coaptation and prevented mitral regurgitation
during acute left ventricular ischemia after ring implantation. (J Thorac
Cardiovasc Surg 2000;119:774-83)
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miniature tantalum radiopaque markers were sutured equidis-
tantly (approximately every 45°) around the circumference of
the mitral anulus (1 near each commissure and 3 along the
anterior and posterior anuli). Additional miniature gold mark-
ers were sutured along the central meridian of the anterior (3
markers) and posterior (2 markers) leaflets with the edge
markers being placed on the ventricular surface. One marker
was placed on each papillary muscle tip. The complete mark-
er array is shown in Fig 1. In the Duran and Physio groups,
ring sizes were chosen on the basis of the area of the anterior
leaflet and the intertrigonal distance (the standard clinical
method); these rings were not undersized. The Duran animals
received five 31-mm rings and one 29-mm ring, whereas a
28-mm ring was implanted in all animals of the Physio group.
Experimental protocol. After 8 ± 4 days (mean ± 1 SD),
each animal was studied in the experimental cardiac catheter-
ization laboratory, sedated (ketamine 1 to 4 mg/kg per hour
intravenous infusion and diazepam 5 mg intravenous bolus as
needed), intubated, and the lungs mechanically ventilated.
Excessive tachycardia was prevented by administration of
UL-FS49 (8 mg intravenously, Boehringer-Ingelheim,
Ridgefield, Conn), a highly specific chronotropic agent that
does not change the QT interval, inotropic state, or systolic or
diastolic blood pressure.13 Esmolol (20 to 50 µg · kg–1 ·
min–1) and atropine sulfate (0.01 mg · kg–1 · min–1) intra-
venous infusions were used to minimize reflex sympathetic
and parasympathetic responses. Balloon occlusion of the left
circumflex coronary artery (distal to the first obtuse marginal
artery) to produce LV posterolateral ischemia was carried out
as previously reported.10 Simultaneous biplane videofluo-
roscopy and hemodynamic data recordings were obtained
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mitral valve reconstruction with an annuloplasty ring
have been developed over the years for prolapse,7 in
patients with MR resulting from coronary artery disease
the leaflets and subvalvular apparatus usually are com-
pletely normal, annular dilatation may be present, yet
leaflet motion typically is either normal (Carpentier type
I) or restricted during systole (Carpentier type IIIb).8 The
combination of these derangements and the underlying
LV dysfunction results in incomplete mitral leaflet coap-
tation, which can be seen with either Carpentier type I or
type IIIb leaflet motion. Mitral annuloplasty alone (usu-
ally with a small ring) is claimed to be efficacious in
treating ischemic MR.6,8,9 It is believed that annular
remodeling allows better approximation of the leaflet
edges, which facilitates leaflet coaptation and prevents
MR. The exact mechanism of how annuloplasty reduces
MR, however, is unknown.
Recent experimental studies have revealed that acute
posterolateral LV ischemia in sheep is associated with
annular dilatation and incomplete mitral leaflet coapta-
tion due to early systolic “loitering” (or delayed clo-
sure) of both leaflets, which can cause ischemic MR.10
Increased end-diastolic mitral septal-lateral (S-L) annu-
lar diameter during ischemia may play a role in the
genesis of incomplete mitral leaflet coaptation and
ischemic MR in this model. Therefore prevention of
annular dilatation and reduction of the S-L annular
dimension by ring annuloplasty may abolish ischemic
MR in this acute model. However, it should also be
considered that ring annuloplasty affects the geometry
and function of the mitral subvalvular complex, which
could theoretically either exacerbate or ameliorate
incomplete mitral leaflet coaptation. In this current
study, we used the myocardial marker technology11 to
investigate the effects of semirigid or flexible ring
annuloplasty on the 3-D geometry and motion of the
mitral valve anulus and leaflets in this experimental
ovine model of acute ischemic MR.
Methods
Surgical preparation. Sixteen adult castrated male sheep
were randomized into three groups: Group C (n = 5) under-
went placement of myocardial markers only to serve as a con-
trol group; the results in these animals have been previously
reported.10 Groups D (n = 6) and P (n = 5) also underwent
annuloplasty with either a Duran ring (Medtronic Heart Valve
Div, Minneapolis, Minn) or a Carpentier-Edwards Physio
ring (Baxter Cardiovascular Div, Santa Ana, Calif), respec-
tively. The surgical preparation has been described in detail
previously12 and will be summarized only briefly. Eight
subepicardial tantalum markers (inner diameter 0.8 mm,
outer diameter 1.3 mm, length 1.5-3.0 mm) were inserted
along 4 equally spaced LV longitudinal meridians. Eight
Fig 1. Array of myocardial and valvular markers used in this
experimental study. APM, Anterior papillary muscle; PPM,
posterior papillary muscle.
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during steady-state conditions and over a range of LV filling
volumes during abrupt preload reduction achieved with vena
caval occluders. Data recordings were acquired initially
before induction of ischemia; after 3 to 5 minutes of stabi-
lization, mid circumflex occlusion was created that resulted
in posterolateral LV ischemia and MR, and data recordings
were repeated. MR was verified by an experienced echocar-
diographer using transthoracic Doppler echocardiography
and graded on the basis of regurgitant jet width and extent
relative to left atrial area: none, 0; mild, +1; moderate, +2;
moderate to severe, +3; and severe, +4. Echocardiography
was performed at the end of the circumflex artery occlusion
(Table I) with the balloon still inflated.
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by
the National Society for Medical Research and “Guide for
the Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources, National Research
Council, and published by the National Academy Press,
revised 1996. This study was approved by the Stanford
Medical Center Laboratory Research Animal Review commit-
tee and conducted according to Stanford University policy.
Data acquisition. Images were acquired with the animal in
the right lateral decubitus position with a Philips Optimus
2000 biplane lateral ARC 2/Poly DIAGNOST C2 system
(Phillips Medical Systems, North America Company,
Pleasanton, Calif) with the image intensifier in the 9-inch flu-
oroscopic mode. Data from two radiographic views were dig-
itized and merged to yield 3-dimensional coordinates for
each of the radiopaque markers every 16.7 seconds with cus-
tom-designed software.14 Descending thoracic aortic pres-
sure, LV pressure, and electrocardiographic voltage signals
were digitized and recorded simultaneously during data
acquisition.
Data analysis 
Hemodynamic and cardiac cycle timing markers. Two con-
secutive steady state beats during control and acute ischemic
conditions were averaged and defined as “control” and
“ischemic” data for each animal, respectively. For each car-
diac cycle, end-systole was defined as the videofluoroscopic
frame containing peak negative LV rate of pressure rise
(–dP/dt), and end-diastole was defined as the videofluoro-
scopic frame containing the peak of the electrocardiographic
R wave. Instantaneous LV volume was calculated from the
epicardial LV markers with a space-filling multiple tetrahe-
dral volume method every 16.7 ms.15 Although LV wall mass
is included in this calculation of LV volume, it accurately
reflects relative changes in LV chamber size16 but does over-
estimate absolute LV chamber volume. Stroke volume (SV)
was calculated as the difference between end-diastolic (EDV)
and end-systolic (ESV) volume (SV = EDV – ESV), and
ejection fraction (EF) was calculated as (EDV – ESV)/EDV.
These computed EFs were underestimates, as the calculated
epicardial LV volumes included myocardial LV wall volume.
LV function. External LV pressure-volume stroke work
(SW) was calculated as the integral of LV pressure (P) multi-
plied by volume (V) over a cardiac cycle for several beats at
baseline and during caval occlusion as follows:
SW = ∫P · dV
Preload recruitable stroke work was computed by linear
regression of SW on EDV as follows:
SW = MW (EDV – VW)
where MW and VW are the slope and volume axis intercepts,
respectively.
Mitral leaflet and annular dynamics. Mitral leaflet coapta-
tion was defined as the minimum distance measured in 3-
dimensional space between the 2 leaflet edge markers after
this value reached a plateau. Mitral annular area was calcu-
lated by determining the centroid of the 8 annular markers,
subsequently dividing the anulus into 8 triangular “pie-
pieces” and summing their 8 individual areas. The S-L diam-
eter was obtained by calculating the linear distance in 3-
dimensional space between the 2 markers placed in the
middle of the anterior (“saddlehorn”) and posterior anulus,
respectively. In similar fashion, the commissure-commissure
(C-C) diameter was calculated as the 3-dimensional distance
between the 2 commissural markers. To describe the 3-
dimensional geometry of the mitral leaflets and papillary tips,
we transformed the marker coordinates from their original
laboratory reference frame to a Cartesian coordinate system
having its origin at the midpoint of the line defining the S-L
diameter, with the Y-axis directed from this origin to the LV
apex marker. In this coordinate system, the positive Y-axis is
directed away from the annular plane toward the LV apex,
and the X-axis is positive toward the lateral LV wall.
Statistical analysis. All data are reported as mean plus or
minus 1 standard deviation (±1 SD) unless otherwise stated.
Hemodynamic and marker-derived data from two steady state
beats were time aligned at end-diastole. Data were analyzed
from two consecutive beats, except in one control animal in
which only one beat was available. The mean and SD for
each variable were computed for 9, 14, and 12 beats in the
control, Duran, and Physio groups, respectively. For calcula-
tions of preload recruitable stroke work in the control group,
8 beats were available since acquisition of caval occlusion
volumes was incomplete in 1 animal. Marker data were ana-
lyzed over 15 frames before and after end-diastole, thus
allowing evaluation over a time period of 500 ms. Data were
compared within each group by means of the Student t test
for paired observations, and intergroup comparisons were
made by means of analysis of variance (ANOVA) with post
Table I. Animal weights, operative times, and duration
of coronary occlusion 
Control Duran Physio ANOVA
Weight (kg) 60 ± 11 70 ± 7 71 ± 11 > .2
Cx balloon occlusion 3.3 ± 3.8 2.5 ± 1.5 2.7 ± 1.8 > .2
time (min)
CPB time (min) 106 ± 9 132 ± 12 134 ± 15 .01
Crossclamp time (min) 58 ± 5 90 ± 5 90 ± 9 .001
Cx, Left circumflex coronary artery; CPB, cardiopulmonary bypass.
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hoc Bonferroni correction. Because of large variances and the
possibility of nonnormally distributed variance, nonparamet-
ric statistical analysis with the Kruskal-Wallis test was also
performed for certain variables.
Results
Marker position was confirmed in all animals at
postmortem examination; LV epicardial markers were
within 1 mm of the epicardial surface, and all mitral
anulus, papillary tip, and leaflet markers were present.
No ring dehiscence or vegetations were noted in the
ring groups. Animal weights, operative times, and dura-
tion of coronary occlusion are summarized in Table I.
No statistically significant difference in weight was
present between the groups. Cardiopulmonary bypass
and crossclamp times were significantly longer in the
Duran and Physio groups. Duration of left circumflex
balloon catheter occlusion was similar in the three
groups.
Hemodynamics. Hemodynamic variables in the
three groups before and after ischemia are presented in
Table II. There was no significant difference between
the groups with respect to heart rate, dP/dt, end-dia-
stolic volume, end-systolic volume, ejection fraction,
LV end-diastolic pressure, and LV end-systolic pres-
sure at baseline or after acute posterolateral ischemia.
(Note that the low computed ejection fractions are not
indicative of profoundly depressed LV systolic func-
tion. These low numbers result from using the LV epi-
cardial markers to calculate end-diastolic and end-sys-
tolic volumes. Therefore, LV wall thickening is not
detected during systole and chamber end-diastolic vol-
ume is markedly overestimated, since LV myocardial
mass is included. These ejection fractions in the low
20s correspond to angiographic LV chamber ejection
fractions of around 0.50.) Although no change in end-
diastolic volume was seen with ischemia in all groups,
end-systolic volume increased in the control group.
Comparable degrees of ischemia were induced in the
three groups as evidenced by a similar decrease in LV
dP/dt (control, –31% ± 12%; Duran, –28% ± 24%;
Physio, –27% ± 7%), and maximum LV pressure (con-
trol, –34% ± 6%; Duran, –26% ± 17%; Physio, –30%
± 6%). Preload recruitable stroke work, a load-inde-
pendent measure of contractility, revealed a somewhat
lesser degree of change during ischemia in the Duran
group (control, –31% ± 9%; Duran, –17% ± 30%;
Physio, –38% ± 24%), but caution is necessary in inter-
preting these changes in the presence of LV regional
systolic wall motion abnormalities accompanying the
ischemic insult.
Mitral valve competence. No MR was detected by
transthoracic Doppler echocardiography at baseline in
the control group. After induction of ischemia, moder-
ate to severe MR developed in 2 animals, and 3 had
mild to moderate MR. In the ring groups, trace MR was
noted in 1 Duran and 1 Physio animal before ischemia,
and the MR did not change with circumflex occlusion.
The remaining sheep did not have MR at baseline or
during ischemia.
Mitral leaflet coaptation and shape. Fig 2 illustrates
the changes in mitral leaflet edge separation, annular
area, and LV pressure at baseline and during acute
ischemia in the three groups. Numerical data and sta-
tistical analysis are summarized in Table III. Valve clo-
sure times, as measured from end-diastole, were not
Table II. Hemodynamic variables in the three groups before and after ischemia
Preischemia Ischemia
Control Duran Physio ANOVA Control Duran Physio ANOVA
HR (min–1) 110 ± 10 113 ± 12 111 ± 10 >.2 93 ± 26 102 ± 26 93 ± 33 >.2
dP/dt
max 
(mm Hg/s) 1985 ± 418 1537 ± 338 1762 ± 372 .19 1386 ± 449† 1087 ± 393 1279 ± 201† >.2
EDV (mL) 140 ± 32 197 ± 43 177 ± 47 .11 145 ± 34 196 ± 40 179 ± 46 .15
ESV (mL) 112 ± 22 159 ± 27 141 ± 44 .08 123 ± 22‡ 168 ± 40 147 ± 44 .16
SV (mL) 29.5 ± 11 38.0 ± 18.1 36.3 ± 5.9 >.2 22.9 ± 13.5* 28.5 ± 4.9 31.6 ± 9.7 >.2
EF 0.20 ± 0.04 0.19 ± 0.05 0.21 ± 0.04 >.2 0.15 ± 0.06* 0.15 ± 0.04 0.18 ± 0.07 .07
LVEDP (mm Hg) 17.9 ± 2.6 26.1 ± 4.7 19.4 ± 6.9 .06 21.3 ± 6.5 22.6 ± 8.0 22.8 ± 5.1 >.2
LVESP (mm Hg) 97 ± 23 101 ± 13 101 ± 14 >.2 64 ± 16* 75 ± 26* 53 ± 11‡ >.2
LVP
max
(mm Hg) 132 ± 18 120 ± 15 121 ± 18 >.2 86 ± 9† 90 ± 26* 85 ± 12† >.2
PRSW (mm Hg/mL) 66.5 ± 10.6 55.1 ± 13.4 69.3 ± 18.7 >.2 45.9 ± 9.6* 43.3 ± 14.8 40.7 ± 15.4* >.2
HR, Heart rate; dP/dt
max
, maximum positive rate of change of LV pressure; EDV, LV end-diastolic volume; ESV, LV end-systolic volume; SV, LV stroke volume; EF,
LV ejection fraction (nota bene: by epicardial markers, not LV chamber EF); LVEDP, LV end-diastolic pressure; LVESP, LV end-systolic pressure; LVP
max
, maximum
systolic LV pressure; PRSW, preload recruitable stroke work. 
*P < .05.
†P < .01. 
‡P < .001.
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significantly different at baseline in the three groups (P
> .2, ANOVA). During ischemia, however, valve clo-
sure in the control group was significantly delayed ver-
sus baseline (16.7 ± 40.9 ms vs 87.7 ± 8.4 ms, P = .02)
and also in comparison with the ischemic valve closure
times in the ring groups (P = .007, ANOVA). The times
of valve closure in the Duran and Physio groups during
ischemia did not differ significantly from preischemic
conditions (Duran 33.4 ± 29.9 ms vs 25.1 ± 25.3 ms, P
> .2; Physio 33.4 ± 23.6 ms vs 30.1 ± 47.8 ms, P > .2).
Due to large variance in the time to valve closure
among the three groups, nonparametric statistical
analysis (Kruskal-Wallis test) revealed no significant
difference in the time of valve closure among the three
groups at baseline (P > .2) and confirmed the signifi-
cance of the delayed valve closure times in the control
group versus the ring groups during posterolateral
ischemia (P = .01).
Leaflet geometry during early systole (2 frames after
end-diastole) in the three groups before and during
Fig 2. Leaflet edge separation (cm), annular area (cm2), and LV pressure (LVP) (mm Hg) before (closed symbols)
and during (open symbols) acute posterolateral LV ischemia. A 500-ms time frame centered at end-diastole
(dashed line) is illustrated for all three groups. Error bars indicate 1 standard error of the mean.
Table III. Numerical data and statistical analysis
Preischemia Ischemia
Control Duran Physio ANOVA Control Duran Physio ANOVA
Time, ED to closure (ms) 16.7 ± 40.9 33.4 ± 29.9 33.4 ± 23.6 >.2 87.7 ± 8.4* 25.1 ± 25.3 30.1 ± 47.8 .007
Annular area at ED (cm2) 6.74 ± 0.64 5.06 ± 0.68 4.75 ± 0.45 .001 8.02 ± 0.89† 5.07 ± 0.70 4.78 ± 0.43 .001
S-L distance at ED (cm) 2.52 ± 0.10 2.23 ± 0.23 2.15 ± 0.12 .01 2.85 ± 0.14* 2.27 ± 0.22* 2.15 ± 0.13 .001
C-C distance at ED (cm) 3.54 ± 0.22 2.86 ± 0.14 2.91 ± 0.34 .001 3.58 ± 0.22 2.83 ± 0.15 2.90 ± 0.36 .001
S-L/C-C at ED 0.71 ± 0.05 0.78 ± 0.06 0.75 ± 0.09 >.2 0.80 ± 0.08 0.80 ± 0.05 0.75 ± 0.11 >.2
MR 0 +0.1 ± 0.2 +0.1 ± 0.2 +2.1 ± 0.8 +0.1 ± 0.2 +0.1 ± 0.2
ED, End-diastole; S-L, septal-lateral dimension of the mitral anulus (from the middle of the anterior anulus [saddlehorn] to the middle of the posterior anulus); C-C,
commissure-commissure dimension of the mitral anulus. 
*P < .05.
†P < .01 by paired t test.
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ischemia is graphically illustrated in Fig 3. At this time
the valve was closed under all experimental conditions
except in the control group during ischemia. In the con-
trol group, both leaflets retained their concave geometry
toward the atrium during ischemia. However, due to
increased separation of their annular hinge points, the
leaflet edge markers were farther apart during early sys-
tole. Coaptation was delayed during ischemia, but the
leaflet edge markers eventually reached the same final
position to close the valve as they did before the
ischemic insult (see Fig 4). In the two ring groups, leaflet
shape was different as evidenced by lack of concavity of
the posterior leaflet and decreased curvature of the ante-
rior leaflet, but this geometry did not change during
ischemia. No separation of the annular hinge points was
noted in either ring group, and leaflet edge separation
during early systole did not change with ischemia.
Mitral annular area and shape. An average increase
of 19% ± 7% in end-diastolic mitral annular area (6.74
± 0.64 cm2 vs 8.02 ± 0.89 cm2, P = .004) was observed
in the control group during ischemia (maximum = 20%
± 7% one frame after end-diastole). At the time of valve
closure, mitral annular area was still 13% ± 9% larger
during ischemia. As listed in Table III, mitral annular
area was smaller than control size in the Duran and
Physio groups but similar between the 2 ring types
(Duran 5.10 ± 0.68 cm2 vs Physio 4.78 ± 0.43 cm2, P >
.2) and remained fixed during the cardiac cycle; more
important, there was no significant change in mitral
annular area between baseline and ischemic conditions,
as depicted in Fig 2.
Changes in S-L and C-C dimensions are shown in
Fig 5 and summarized in Table III. In the control group,
a significant increase in S-L distance (14% ± 9%) was
observed at end-diastole during ischemia, in contrast to
a negligible change (+1.6% ± 3.6%) in the C-C dis-
Fig 3. Leaflet shape (derived from the 3-dimensional coordi-
nates of leaflet markers) during early systole (2 frames [33.4
ms] after end-diastole) under baseline (solid symbols) and
ischemic (open symbols) conditions for all three groups. At
this time the valve is closed under all experimental conditions
except ischemic control. Error bars indicate 1 standard error
of the mean.
Fig 4. Leaflet shape, derived from the 3-dimensional coordi-
nates of leaflet markers, at the time of valve closure in the
control group before (closed circles) and during (open cir-
cles) acute posterolateral ischemia. The graphs represent
leaflet shape at 16.7 ms and 83.5 ms after end-diastole for
preischemic and ischemic valve closure, respectively. Error
bars indicate 1 standard error of the mean.
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tance. These geometric changes led to an increase in
the S-L/C-C ratio of the mitral anulus at end-diastole
under ischemic conditions (0.71 ± 0.05 vs 0.80 ± 0.08,
P = .02). Under both baseline and ischemic conditions,
the S-L and C-C dimensions were quite dynamic
throughout the cardiac cycle in the control group. In the
Duran ring group, the S-L dimension varied little dur-
ing the cardiac cycle, although a small increase was
noted at end-diastole during ischemia (2.23 ± 0.23 cm
vs 2.27 ± 0.22 cm, P = .05). The C-C dimension
remained fixed throughout the cardiac cycle during
ischemia. In the Physio ring group, even less variabili-
ty in S-L and C-C dimensions was observed (ie, mitral
annular size and shape were fixed during control and
ischemia). As expected, both S-L and C-C dimensions
in both ring groups were significantly smaller than
those in the control group, during both baseline and
ischemic conditions.
Papillary muscles. No significant change in the 3-
dimensional coordinates of the posterior and anterior
papillary muscle tips from baseline was noted at end-
diastole in any of the three groups during the acute
ischemic insult.
Discussion
The pathophysiology of ischemic MR has been
ascribed to pathologic perturbations in the 3-dimen-
sional geometry of the left ventricle and the mitral sub-
valvular apparatus due to ischemia and infarction.
Annular changes,10,17 systolic leaflet tethering,18,19
more spherical ventricular shape,20,21 and depressed
systolic function22 have all been thought to contribute
to this process. Mitral annuloplasty alone is believed to
be effective in abolishing ischemic MR in some
patients with normal valve morphology, yet the precise
mechanism of how annular fixation prevents ischemic
MR is not known, and satisfactory clinical results are
not uniformly reproducible. Whether simple annular
reduction or attendant changes in the 3-dimensional
geometry of the subvalvular apparatus or both are
responsible is speculative. This experiment demon-
strated that delayed leaflet coaptation and MR during
acute LV ischemia can be prevented by just reducing
and fixing annular size.
Mitral leaflet coaptation and mitral annular area.
During acute LV ischemia, leaflet coaptation was sig-
nificantly delayed in the control group, as previously
Fig 5. Septal-lateral (SL) distance (cm), commissure-commissure (CC) dimension (cm), and LV pressure (LVP)
(mm Hg) before (closed symbols) and during (open symbols) acute posterolateral LV ischemia. A 500-ms time
frame centered at end-diastole (dashed lines) is shown for all three groups. Error bars indicate 1 standard error
of the mean.
described,10 and this early systolic leaflet “loitering”
was associated with MR. Annular dilatation was maxi-
mal during this period, and therefore the leaflets had to
traverse more distance to reach coaptation. As the tim-
ing of the regurgitant jet could not be determined, no
concrete cause-and-effect relationship between delayed
leaflet coaptation and regurgitation was possible. A
canine experiment showed that an isolated 25%
increase in mitral annular circumference with an exter-
nally adjustable rigid mitral ring resulted in 3+ MR,23
which resolved when the ring was reduced to its origi-
nal size. This increase in annular dimension would
result in a greater increase in area than that observed in
our study but illustrates that MR can result from annu-
lar dilatation alone. Rigid fixation with an oversized
mitral ring was also observed to cause valve incompe-
tence by other investigators in dogs,24 but mitral ring
annuloplasty with either a flexible or semiflexible ring
reduced annular size such that dilatation did not occur
during ischemia. Similar mitral annular fixation in our
study abolished both ischemic MR and delayed leaflet
coaptation. Therefore, by bringing the leaflets closer
together at end-diastole, annuloplasty may allow for
timely systolic coaptation and nonregurgitant closure
during ischemia. This notion is indirectly supported by
the work of Bolling and associates,25 who observed
that annuloplasty alone was effective in reducing MR
in patients with idiopathic dilated cardiomyopathy,
who generally had normal leaflet motion (Carpentier
type I) before the operation. On the other hand,
ischemic MR can persist in patients after annuloplasty
because of apical tenting of the leaflets, which restricts
closing during systole (Carpentier type IIIb leaflet
motion).26 Thus more than one mechanism may be
responsible for MR in chronically volume-overloaded
dilated human hearts.
Mitral leaflet area has been reported to exceed the
annular orifice by 52% in sheep,27 and this gross redun-
dancy was believed to preclude MR from occurring due
to annular dilatation alone. It is the combined height of
both leaflets in the S-L axis, however, that is primarily
responsible for valvular competence. As leaflet coapta-
tion occurs apically to the annular plane and the leaflets
are usually thought to be concave (to the ventricle) dur-
ing closure, redundancy of the combined leaflet height
may effectively be much less with respect to the S-L
annular dimension. Therefore small changes in the S-L
diameter, such as those observed with our model of
acute LV ischemia, may perturb this relationship suffi-
ciently to create incomplete mitral leaflet coaptation.
Annuloplasty increases the ratio of mitral leaflet to
annular area and thereby promotes coaptation primari-
ly by reducing the S-L annular dimension.
Mitral annular shape. The alterations in annular
dimensions in the control group during ischemia were
characterized by a significant increase in the S-L diam-
eter with little change in the C-C axis, corresponding to
the findings of others.28 These observations corre-
sponded with a more circular shape of the anulus at
end-diastole. Ring annuloplasty abolished these shape
changes during the cardiac cycle and significantly
reduced both the S-L and C-C dimensions. A smaller,
fixed S-L diameter after ring annuloplasty would facil-
itate valve closure as it acts orthogonal to the leaflet
coaptation zone. Therefore an important mechanism of
ring annuloplasty may be reducing the S-L dimension,
since this is the principal direction of annular enlarge-
ment during ischemia.8,10,28 This concept is corroborat-
ed by a recent study from our laboratory in which
experimental manipulation that enlarged the C-C axis
(but not the S-L axis) resulted in a 15% to 17% increase
in mitral annular area that was not associated with any
MR.29 Interestingly, the 1 animal that did have MR had
an increase in the S-L diameter of greater than 2 SDs
larger than the mean value, in addition to considerable
C-C dilatation. Czer and associates9 compared the effi-
cacy of ring versus suture annuloplasty in patients
undergoing coronary revascularization and mitral valve
repair and found a greater degree of postoperative MR
in the suture annuloplasty group; moreover, patients in
the ring group had a greater reduction in S-L mitral
diameter as measured echocardiographically. Since
dilatation of the posterior anulus is primarily responsi-
ble for the augmented mitral annular S-L dimension,
our findings suggest that simple posterior annuloplasty
alone may possibly be sufficient to prevent ischemic
MR
Papillary muscle geometry. No difference in papil-
lary muscle tip position during ischemia was noted in
the three groups at end-diastole compared with base-
line. (Note that our previously mentioned very small
change in end-diastolic posteromedial papillary muscle
tip position10 in these same control animals was due to
a timing difference in defining end-diastole [beginning
of the R-wave upstroke in our 1998 report and the peak
of the QRS signal now] and a technical error on our
part in temporal registration. The data shown in this
article for the papillary muscle tip positions were vali-
dated by three individuals working independently.)
Since annuloplasty was not associated with end-dia-
stolic papillary muscle displacement during ischemia,
yet abolished MR and early systolic incomplete mitral
leaflet coaptation, it is reasonable to conjecture that
incomplete coaptation was primarily due to annular
dilatation (which is maximal during this time period)
and not due to leaflet tethering. Although acute MR
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resulting from leaflet tethering has been described in
the dog,19 “functional” MR in that study was due to
combined global LV ischemia and LV dilation. As nei-
ther end-diastolic volume nor papillary position
changed with ischemia in our study, leaflet tethering is
an unlikely mechanism for leaflet loitering and incom-
plete mitral leaflet coaptation during acute posterolat-
eral LV ischemia in this experimental preparation.
Study limitations 
First, it must be emphasized that previous implanta-
tion of an annuloplasty ring before the ischemic insult
(“prevention” of ischemic MR as shown here) is clear-
ly not analogous to the clinical situation, in which
ischemia or an infarction occurs and then is treated sur-
gically with placement of a ring. This is a major and
important limitation of this model. Second, these find-
ings can be interpreted only in the setting of acute LV
ischemia in a normal sheep heart and cannot be extrap-
olated directly to chronic ischemic MR where LV
dilatation, subvalvular geometric perturbations induced
by previous infarction and ischemia, and LV remodel-
ing may play a more predominant role. This point must
be emphasized because chronic MR in a clinical situa-
tion may alter annular geometry and function in ways
not reflected in our acute experimental model. Thus,
although our ovine preparation provides valuable data
regarding mechanisms and treatment of acute ischemic
MR, caution must be used in extrapolating these data in
the human setting of chronic MR. Third, it was not pos-
sible in this study to determine the exact timing of the
MR; therefore, the MR created by circumflex occlusion
in this sheep model could have occurred in late systole
and not be related to the delayed coaptation and incom-
plete mitral leaflet coaptation seen in early systole. This
is unlikely, however, as no MR was observed in the ring
groups when delayed leaflet closure was also prevent-
ed. Further studies are needed to better characterize the
timing of ischemic MR in this experimental prepara-
tion.
As the leaflet markers were placed only on the cen-
tral meridian of each leaflet, no data are available
pertaining to leaflet motion and coaptation near the
commissures or involving the anterolateral or postero-
medial leaflet scallops, where delayed coaptation may
also be present. We are planning future experiments
with a denser array of leaflet edge markers to address
this question. The myocardial marker method provides
reproducible determination of 3-dimensional marker
positions with sub-millimeter spatial resolution every
16.7 ms, but it requires suturing small metal markers to
intracardiac structures. It is unlikely that the markers
interfered with mitral leaflet motion because they are
very small (aggregate mass = 20 ± 6 mg); even when
we grossly overloaded the anterior leaflet with a larger
number of excessively heavy markers (total mass = 184
mg) in other animals, the peak anterior leaflet opening
velocity by epicardial pulse wave Doppler echocardio-
graphy was 0.47 ± 0.05 m/s compared with 0.45 ± 0.06
m/s for leaflets without any markers implanted. The
peak E-wave velocities ranged from 0.55 to 0.60 m/s
(unpublished data).
Finally, this animal model has other intrinsic limita-
tions; sheep have a less defined posterior anulus than
human beings and more atrial tissue above and below
the line of leaflet insertion.30 The amount of atrial
fibers in the human anulus, however, is quite variable.31
Nonetheless, extrapolation of these results to clinical
situations must be done with caution. On the other
hand, the ovine model is more relevant to human
pathophysiology than the canine model, because the
dog heart has multiple pre-formed coronary collater-
als.32 Finally, to get close to the real clinical problem,
this type of investigation needs to be conducted in
long-term animal preparations after myocardial infarc-
tion with subsequent ischemic MR, LV remodeling,
and chronic volume overload.
We appreciate the superb technical assistance provided
by Mary K. Zasio, BA, Carol W. Mead, BA, and Erin K.
Schultz, BS. 
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